Literature DB >> 6578675

The Social Insurance Institution's coronary heart disease study. Baseline data and 5-year mortality experience.

A Reunanen, A Aromaa, K Pyörälä, S Punsar, J Maatela, P Knekt.   

Abstract

The Social Insurance Institution's Coronary Heart Disease Study is a prospective population study designed to investigate the prevalence, risk factors and incidence of coronary heart disease (CHD) in middle-aged Finnish men and women. The study population consisted of 5 738 men and 5 224 women, aged 30-59 years at entry, drawn from 12 cohorts from south-western, western, central and eastern Finland. The cohorts consisted of whole or random samples of rural or semiurban dwellers or employees of a factory. The participation rate was 90 per cent. The prevalence of symptoms was determined by the Rose questionnaire and abnormalities on resting ECG were coded according to the Minnesota code. Blood pressure, smoking habits, serum cholesterol, triglycerides, postload plasma glucose and obesity were the risk factors analysed at the baseline examination. The mortality of examinees has been followed continuously. This report deals with the main findings at the baseline examination and the mortality follow-up experience in 5 years. The prevalence of typical angina pectoris was 4.4 per cent in men and 5.4 per cent in women. Unequivocal ECG signs of past myocardial infarction were observed in 1.0 per cent of men and 0.3 per cent of women. Other ECG findings suggesting CHD were observed in 9.2 per cent of men and 11.1 per cent of women. The 5-year mortality was 4.3 per cent in men and 0.9 per cent in women. Men with typical chest pain symptoms had a seven-fold risk to die from CHD, compared to men without symptoms. Men with ECG abnormalities compatible with an old infarction had a 19.5-fold and men with other ECG findings suggesting CHD a 7.1-fold risk to die from CHD compared to men without resting ECG abnormalities. Men with ECG findings as the only indicator of CHD had worse survival than men with symptoms as the only indicator of CHD. The value of symptoms and ECG findings as predictors of CHD mortality in women was very low.

Entities:  

Mesh:

Year:  1983        PMID: 6578675

Source DB:  PubMed          Journal:  Acta Med Scand Suppl        ISSN: 0365-463X


  25 in total

1.  Prevalence of and risk factors for exertional chest pain in older Mexican Americans.

Authors:  Kushang V Patel; Sandra A Black; Kyriakos S Markides
Journal:  Am J Public Health       Date:  2003-03       Impact factor: 9.308

2.  QT interval as a cardiac risk factor in a middle aged population.

Authors:  J Karjalainen; A Reunanen; P Ristola; M Viitasalo
Journal:  Heart       Date:  1997-06       Impact factor: 5.994

3.  Risk factors for sciatica leading to hospitalization.

Authors:  Ulla Euro; P Knekt; H Rissanen; A Aromaa; J Karppinen; M Heliövaara
Journal:  Eur Spine J       Date:  2017-06-13       Impact factor: 3.134

4.  The Origins and Early Evolution of Epidemiologic Research in Cardiovascular Diseases: A Tabular Record of Cohort and Case-Control Studies and Preventive Trials Initiated From 1946 to 1976.

Authors:  Henry Blackburn
Journal:  Am J Epidemiol       Date:  2019-01-01       Impact factor: 4.897

5.  Reduced risk of Parkinson's disease associated with lower body mass index and heavy leisure-time physical activity.

Authors:  Katri Sääksjärvi; Paul Knekt; Satu Männistö; Jukka Lyytinen; Tuija Jääskeläinen; Noora Kanerva; Markku Heliövaara
Journal:  Eur J Epidemiol       Date:  2014-03-16       Impact factor: 8.082

6.  Autoantibodies binding to citrullinated telopeptide of type II collagen and to cyclic citrullinated peptides predict synergistically the development of seropositive rheumatoid arthritis.

Authors:  Marja-Kaisa Koivula; Markku Heliövaara; Jarmo Ramberg; Paul Knekt; Harri Rissanen; Timo Palosuo; Juha Risteli
Journal:  Ann Rheum Dis       Date:  2007-05-01       Impact factor: 19.103

7.  The relative importance of modifiable potential risk factors of type 2 diabetes: a meta-analysis of two cohorts.

Authors:  Maarit A Laaksonen; Paul Knekt; Harri Rissanen; Tommi Härkänen; Esa Virtala; Jukka Marniemi; Arpo Aromaa; Markku Heliövaara; Antti Reunanen
Journal:  Eur J Epidemiol       Date:  2009-12-13       Impact factor: 8.082

8.  Prevalence of coronary heart disease, left ventricular failure and hypertension in middle-aged, newly diagnosed type 2 (non-insulin-dependent) diabetic subjects.

Authors:  M Uusitupa; O Siitonen; A Aro; K Pyörälä
Journal:  Diabetologia       Date:  1985-01       Impact factor: 10.122

Review 9.  Clinical cardiac PET using generator-produced Rb-82: a review.

Authors:  K L Gould
Journal:  Cardiovasc Intervent Radiol       Date:  1989 Sep-Oct       Impact factor: 2.740

10.  Estimating clinical morbidity due to ischemic heart disease and congestive heart failure: the future rise of heart failure.

Authors:  L Bonneux; J J Barendregt; K Meeter; G J Bonsel; P J van der Maas
Journal:  Am J Public Health       Date:  1994-01       Impact factor: 9.308

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.